<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00179868</url>
  </required_header>
  <id_info>
    <org_study_id>SCT 0403 CRP</org_study_id>
    <nct_id>NCT00179868</nct_id>
  </id_info>
  <brief_title>C-Reactive Protein as a Predictor of Stem Cell Transplant Complications</brief_title>
  <official_title>C-Reactive Protein As a Predictor of Major Transplant Complications in Pediatric Stem Cell Transplant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ann &amp; Robert H Lurie Children's Hospital of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ann &amp; Robert H Lurie Children's Hospital of Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if C-Reactive Protein levels are predictive for
      complications post transplant.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To determine whether quantitative c-reactive protein measurements can predict major morbidity and mortality in pediatric stem cell transplant patients.</measure>
    <time_frame>To day +100 post transplant</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Cancer</condition>
  <condition>Leukemia</condition>
  <condition>Stem Cell Transplantation</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>C-Reactive Protein levels</intervention_name>
    <description>Each patient enrolled in the study will have a serum quantitative c-reactive protein (crp) level drawn on the day of transplant, day 7 of transplant, and twice weekly after that until recovery of neutrophil count (approximately 20-25 days). Patients will be followed for 100 days post-transplant for the development of the following complications:
Sepsis- defined as fever, positive blood culture, need for fluid resuscitation and/or pressor support.
Acute GVHD &gt; grade II defined according to the Seattle criteria
VOD- defined according to the modified Seattle criteria</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Children undergoing a stem cell transplant
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 6 months to 20 years

          -  Patient undergoing a stem cell transplant (allogeneic, syngeneic, or autologous) at
             Childrens' Memorial Hospital

          -  IRB approved informed consent (and assent for children age 12-17)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>20 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Morris Kletzel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ann &amp; Robert H Lurie Children's Hospital of Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2005</study_first_submitted>
  <study_first_submitted_qc>September 10, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>August 26, 2008</last_update_submitted>
  <last_update_submitted_qc>August 26, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2008</last_update_posted>
  <responsible_party>
    <name_title>Morris Kletzel, MD</name_title>
    <organization>Children's Memorial Hospital</organization>
  </responsible_party>
  <keyword>cancer</keyword>
  <keyword>leukemia</keyword>
  <keyword>stem cell transplant</keyword>
  <keyword>complications</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

